Efficacy and Safety of Selinexor in Recurrent Glioblastoma

被引：0

作者：

Lassman, A. B. ^{[1
]}

Wen, P. Y. ^{[2
]}

van den Bent, M. ^{[3
]}

Plotkin, S. R. ^{[4
]}

Walenkamp, A. ^{[5
]}

Green, A. ^{[2
,6
]}

Huang, X. ^{[7
]}

Rodriguez-Lopez, K. Karla ^{[7
]}

Kauffman, M. G. ^{[7
]}

Shacham, S. ^{[7
]}

Mau-Soerensen, M. ^{[8
]}

机构：

[1] Columbia Univ, Irving Med Ctr, New York, NY USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Erasmus MC Canc Ctr, Rotterdam, Netherlands

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

[5] Univ Groningen, Groningen, Netherlands

[6] Univ Colorado, Ctr Canc, Aurora, CO USA

[7] Karyopharm Therapeut Inc, Newton, MA USA

[8] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark

来源：

NEUROTHERAPEUTICS | 2020年 / 17卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1315 / 1316

页数：2

共 50 条

[21] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
Matteo Santoni
Silvia Scoccianti
Ivan Lolli
Maria Grazia Fabrini
Giovanni Silvano
Beatrice Detti
Franco Perrone
Giuseppina Savio
Roberto Iacovelli
Luciano Burattini
Rossana Berardi
Stefano Cascinu
Journal of Neuro-Oncology, 2013, 113 : 397 - 401
[22] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
Santoni, Matteo
Scoccianti, Silvia
Lolli, Ivan
Fabrini, Maria Grazia
Silvano, Giovanni
Detti, Beatrice
Perrone, Franco
Savio, Giuseppina
Iacovelli, Roberto
Burattini, Luciano
Berardi, Rossana
Cascinu, Stefano
JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (03) : 397 - 401
[23] SAFETY AND EFFICACY OF BEVACIZUMAB AND ERLOTINIB FOR RECURRENT GLIOBLASTOMA PATIENTS IN A PHASE II STUDY
Sathornsumetee, Sith
Desjardins, Annick
Vredenburgh, James
Rich, Jeremy
Gururangan, Sridharan
Friedman, Allan
Friedman, Henry
Reardon, David
NEURO-ONCOLOGY, 2008, 10 (05) : 827 - 827
[24] Efficacy and Safety of Selinexor for Acute Myeloid Leukemia: A Systematic Review
Hashmi, Mydah Sajid
Sharif, Muhammad Ans
Jaan, Ali
Salman, Umer
Aziz, Summera
Shahab, Asna
Ahmed, Zahoor
Tariq, Muhammad Junaid
Haider, Mobeen Zaka
Anwer, Faiz
BLOOD, 2020, 136
[25] The efficacy of temozolomide for recurrent glioblastoma multiforme
Chen, Chao
Xu, Tao
Lu, Yicheng
Chen, Juxiang
Wu, Shenhong
EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (02) : 223 - 230
[26] Safety and efficacy of carboplatin monotherapy dosed utilizing the Calvert formula in recurrent glioblastoma multiforme
Glass, Jon
NEURO-ONCOLOGY, 2006, 8 (04) : 443 - 443
[27] BEVACIZUMAB IN COMBINATION WITH IRINOTECAN OR TEMOZOLOMIDE IN RECURRENT GLIOBLASTOMA: EFFICACY AND SAFETY RESULTS FROM A PILOT STUDY
Kobyakov, Grigory
Absalyamova, O.
Amanov, R.
NEURO-ONCOLOGY, 2010, 12 : 54 - 54
[28] A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Wen, Patrick Y.
Schiff, David
Cloughesy, Timothy F.
Raizer, Jeffrey J.
Laterra, John
Smitt, Melanie
Wolf, Michael
Oliner, Kelly S.
Anderson, Abraham
Zhu, Min
Loh, Elwyn
Reardon, David A.
NEURO-ONCOLOGY, 2011, 13 (04) : 437 - 446
[29] Safety and efficacy study of retifanlimab and epacadostat in combination with radiation and bevacizumab in patients with recurrent glioblastoma.
Campian, Jian Li
Abraham, Christopher
Luo, Jingqin
Talcott, Grayson
Katumba, Ruth
Kim, Albert H.
Dunn, Gavin P.
Ansstas, George
Johanns, Tanner Michael
Ciorba, Matthew A.
Chheda, Milan G.
Huang, Jiayi
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[30] SAFETY AND EFFICACY OF BEVACIZUMAB AND METRONOMIC, ORAL ETOPOSIDE FOR RECURRENT GLIOBLASTOMA PATIENTS IN A PHASE II STUDY
Reardon, David
Desjardins, Annick
Vredenburgh, James
Rich, Jeremy
Gururangan, Sridharan
Sathornsumetee, Sith
Friedman, Allan
Friedman, Henry
NEURO-ONCOLOGY, 2008, 10 (05) : 839 - 839

← 1 2 3 4 5 →